Keyphrases
Academic Hospital
20%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
23%
AIDS/HIV
12%
Amniotic Fluid Stem Cells
32%
Atopic Dermatitis
46%
Balb C Mice
11%
Batik
18%
Batik Worker
20%
Beneficial Effects
14%
COVID-19
28%
Disability
14%
Disease Severity
10%
Epigallocatechin-3-gallate
12%
Erythema Nodosum Leprosum
14%
Fractional CO2 Laser
17%
Fractional Laser
10%
General Hospital
12%
Growth Factors
16%
Healing
11%
Healthcare Workers
12%
Indonesia
77%
Indonesian
17%
Intervertebral Disc Degeneration
11%
Leprosy
100%
Leprosy Patients
42%
Mesenchymal Stem Cells
13%
Meta-analysis
11%
Metabolic Products
13%
Methotrexate
12%
Microneedles
10%
Mycobacterium Leprae
21%
Neutrophil-to-lymphocyte Ratio
10%
Non-endemic
13%
Occupational Contact Dermatitis
10%
Outpatient Clinic
19%
Photoaging
44%
Picosecond Laser
12%
Plantar Ulcer
15%
Randomized Controlled Trial
16%
Resveratrol
12%
Risk Factors
20%
SCORing Atopic Dermatitis (SCORAD)
10%
Secretome
14%
Skin Prick Test
15%
Stem Cell Conditioned Medium
24%
Surabaya
47%
Ultraviolet-B (UV-B)
11%
Vitamin C
15%
Vitiligo
13%
Yogyakarta
10%
Medicine and Dentistry
Adipose Tissue
9%
Adverse Event
6%
Amniotic Stem Cell
32%
Ascorbic Acid
19%
Carbon Dioxide
14%
Clinical Trial
6%
Cohort Effect
9%
COVID-19
21%
Cross Sectional Study
9%
Dermatology
19%
Diagnosis
16%
Diseases
28%
Division
11%
Epigallocatechin Gallate
12%
Erbium
12%
Erythema Nodosum Leprosum
16%
Hansen's disease
7%
Immunohistochemistry
7%
In Vitro
6%
Infection
19%
Interstitial Collagenase
8%
Low Level Laser Therapy
8%
Lymphocyte
7%
Medical Record
11%
Mesenchymal Stem Cell
13%
Metabolite
10%
Methotrexate
9%
Multibacillary Leprosy
7%
Mycobacterium leprae
13%
Neutrophil
7%
Outpatient
26%
Pediatrics
8%
Photoaging
47%
Phototherapy
13%
Plantar Ulcer
19%
Polypharmacy
8%
Prevalence
8%
Psoriasis
15%
Public Health
8%
Quality of Life
10%
Randomized Controlled Trial
9%
Rejuvenation
9%
Retrospective Study
46%
Side Effect
6%
Skin Type
9%
Stem Cell
17%
Systematic Review
9%
Ulcer
17%
Venereology
13%
Vitiligo
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
6%
Allergen
11%
Alpha Tocopherol
6%
Ascorbic Acid
9%
Atopic Dermatitis
45%
Candida
11%
Carbon Dioxide
12%
Contact Dermatitis
7%
Coronavirinae
21%
Cross-Sectional Study
12%
Cytokine
8%
Dermatitis
15%
Diseases
34%
Epigallocatechin Gallate
19%
Erbium
9%
Erythema Nodosum Leprosum
6%
Fatty Acid
7%
Framycetin
5%
Growth Factor
11%
HIV
15%
Hydration
6%
Hypoxia
6%
Immunoglobulin E
7%
Infection
9%
Intervertebral Disk Degeneration
6%
Lactobacillus plantarum
9%
Methotrexate
12%
Mycobacterium leprae
7%
Nystatin
8%
Occupational Eczema
12%
Occupational Skin Disease
6%
Photoaging
31%
Placebo
12%
Plantar Ulcer
15%
Prednisolone
6%
Prevalence
13%
Psoriasis
17%
Psoriasis Vulgaris
10%
Randomized Clinical Trial
6%
Randomized Controlled Trial
19%
Retinoic Acid
6%
Retrospective Study
24%
Side Effect
11%
Staphylococcus Aureus
6%
Stria
6%
Thrush
9%
Treatment Group
5%
Ulcer
13%
Vitamin D
6%
Wound Healing
8%